Multiple sclerosis is associated with complex pathogenic autoimmunity directed against CNS components, with several of the myelin proteins, such as MBP, PLP, MOG, and MOBP, being the major potential target antigens in MS. This evidence concerns the gene MOG and myeloid sarcoma.